发明名称 |
FUSION MOLECULE AND METHOD FOR TREATMENT OF IMMUNE DISEASE |
摘要 |
PROBLEM TO BE SOLVED: To provide new and/or improved therapeutic strategies for the treatment of immune diseases resulting from inappropriate or unwanted immune response. SOLUTION: The invention provides an isolated fusion molecule comprising a first polypeptide sequence specifically binding to a native IgG inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells, functionally connected to a second polypeptide sequence specifically binding indirectly to a native IgE receptor (FcεR). COPYRIGHT: (C)2010,JPO&INPIT
|
申请公布号 |
JP2010180223(A) |
申请公布日期 |
2010.08.19 |
申请号 |
JP20100068345 |
申请日期 |
2010.03.24 |
申请人 |
REGENTS OF THE UNIV OF CALIFORNIA |
发明人 |
SAXON ANDREW;ZHANG KE;ZHU DAOCHENG |
分类号 |
C07K16/28;C12N15/09;A61K35/76;A61K38/00;A61K47/48;A61K48/00;A61P1/04;A61P1/08;A61P1/12;A61P3/00;A61P9/00;A61P9/06;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P17/04;A61P19/02;A61P25/00;A61P27/14;A61P27/16;A61P29/00;A61P37/08;A61P43/00;C07K14/415;C07K14/435;C07K14/47;C07K16/00;C07K16/46;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|